Table 1: Clinical, para-clinical and evolutionary characteristics of the facial paralysis.
|
Case |
Age at the diagnosis of PF |
Sex |
Characteristics of PF |
Other involvments |
Biology |
ECA |
Treatment |
Outcome |
|
1
|
29 |
F |
Revealing Left |
Mediastinallymphnodes Interstitialpneumopathy Central neurologicalimpairment |
Hypercalciurae/ Lymphopenia |
Nl |
Oral CT (0,7 mg/kg/day) Methotrexate
|
Decrease of FP |
|
2
|
52 |
F |
Revealing Left |
Granulomatousanterioruveitis Central neurologicalimpairment Interstitialpneumopathy |
- |
Oral CT (1mg/kg/day) |
Decrease of FP |
|
|
3
|
62 |
F |
Revealing Bending |
MediastinallymphnodeS Interstitialpneumopathy
|
Hypercalcemia |
Nl |
Oral CT (0,5mg/kg/day) |
Decrease of FP |
|
4 |
45 |
F |
Revealing Left |
Bilateralgranulomatouspanuveitis Mediastinallymphnode
Meningitidis |
Lymphopenia |
Oral CT (1mg/kg/day) |
Decrease of FP |
|
|
5 |
40 |
F |
Revealing Bending Recurrent |
BilateralgranulomatousanterioruveitisMediastinallymphnode Interstitialpneumopathy |
Lymphopenia |
Oral CT (1mg/kg/day) |
Recurrence of FP |
|
|
6 |
39 |
M |
Left |
Bilateralgranulomatouspanuveitis Central neurologicalimpairment |
HypercalcemiaHypercalciuria |
Nl |
Oral CT (1mg/kg/day) |
Decrease of FP |
|
7 |
50 |
M |
Revealing Bending Recurrent |
Parotidis Erythemanodosum Granulomatousanterioruveitis |
Lymphopenia |
Oral CT (1mg/kg/day) |
Decrease of FP |
Abreviations: ECA: FP : Facial Paralysis; F: Female; M : Male; CT : Corticosteroids